Stereotaxis (STXS) Non-Current Debt (2010 - 2021)

Stereotaxis (STXS) posted quarterly Non-Current Debt of $243617.0 for Q1 2021, down 74.97% quarter-over-quarter from $973252.0 in Q4 2020.

Stereotaxis (STXS) Non-Current Debt (2010 - 2021) Analysis & Trends

Stereotaxis (STXS) has reported Non-Current Debt for 9 consecutive years, with $243617.0 the latest figure, recorded in Q1 2021.

In Q1 2021, Non-Current Debt changed N/A year-over-year to $243617.0; the TTM figure through Mar 2021 stood at $243617.0 (changed N/A YoY), while the FY2020 annual figure was $973252.0, changed N/A from the prior year.
Non-Current Debt declined to $243617.0 in Q1 2021 per STXS's latest filing, from $973252.0 in the prior quarter.
Across five years, Non-Current Debt topped out at $1.7 million in Q3 2020 and bottomed at $243617.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	13.51 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	4.15 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	399.42 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	12.55 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	202.90 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	4.57 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	1.86 Bn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	8.62 Bn
10	Stereotaxis	141.91 Mn	127.29 Mn	3.79 Mn	-

Download Data